{"id":4272,"date":"2025-02-14T12:05:06","date_gmt":"2025-02-14T11:05:06","guid":{"rendered":"https:\/\/www.symatese.com\/?p=4272"},"modified":"2025-02-14T12:05:06","modified_gmt":"2025-02-14T11:05:06","slug":"symatese-secures-fda-approval-for-evolysse","status":"publish","type":"post","link":"https:\/\/www.symatese.com\/fr\/news\/symatese-secures-fda-approval-for-evolysse\/","title":{"rendered":"SYMATESE obtient l'approbation de la FDA pour EVOLYSSE\u2122"},"content":{"rendered":"<p><strong>Premi\u00e8re avanc\u00e9e technologique majeure dans le domaine des produits de comblement de rides \u00e0 base d'acide hyaluronique depuis une d\u00e9cennie.<\/strong><\/p>\n<p><strong>SYMATESE franchit une \u00e9tape importante de son histoire et annonce l'approbation par la FDA des gels d'acide hyaluronique injectables EVOLYSSE\u2122 FORM et EVOLYSSE\u2122 SMOOTH.<\/strong><\/p>\n<p>SYMATESE r\u00e9alise une avanc\u00e9e majeure avec EVOLUS, en obtenant l'approbation de la FDA pour EVOLYSSE\u2122 FORM et EVOLYSSE\u2122 SMOOTH, des gels injectables d'acide hyaluronique de nouvelle g\u00e9n\u00e9ration aliment\u00e9s par la technologie de pointe COLD-X\u2122 TECHNOLOGY. Con\u00e7ues pour des r\u00e9sultats durables et d'apparence naturelle, ces innovations seront exclusivement lanc\u00e9es aux \u00c9tats-Unis par Evolus au deuxi\u00e8me trimestre 2025. Cette \u00e9tape marque l'entr\u00e9e audacieuse de SYMATESE sur le march\u00e9 am\u00e9ricain des produits de comblement dermique, d'une valeur de 1,6 milliard de dollars, et acc\u00e9l\u00e8re son expansion mondiale, avec des lancements \u00e0 venir en Europe, en Chine et au Br\u00e9sil.<\/p>\n<p><a href=\"https:\/\/www.symatese.com\/wp-content\/uploads\/2025\/02\/Communique-de-presse_PMA_EVOLYSSE_FEV-2025.pdf\" target=\"_blank\" rel=\"noopener\">Lire le communiqu\u00e9 de presse<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>First Major Technological Breakthrough in HA Dermal Fillers in a Decade SYMATESE reaches a milestone in its history and announces FDA Approval of EVOLYSSE\u2122 FORM and EVOLYSSE\u2122 SMOOTH Injectable Hyaluronic Acid Gels. SYMATESE achieves a major breakthrough with EVOLUS, getting the FDA approval of EVOLYSSE\u2122 FORM and EVOLYSSE\u2122 SMOOTH, next-generation hyaluronic acid injectable gels powered [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4277,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wds_primary_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4272","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts\/4272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/comments?post=4272"}],"version-history":[{"count":1,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts\/4272\/revisions"}],"predecessor-version":[{"id":4275,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts\/4272\/revisions\/4275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/media\/4277"}],"wp:attachment":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/media?parent=4272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/categories?post=4272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/tags?post=4272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}